About: Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease
Creator	Barrios, Clara Pascual, Julio Riera, Marta Soler, María Anguiano, Lidia Betriu, Angels Fernández, Elvira Mojal, Sergi Valdivielso, José
Source	PMC
abstract	BACKGROUND: Patients with cardiovascular (CV) disease have an increased circulating angiotensin-converting enzyme 2 (ACE2) activity, but there is little information about changes in ACE2 in chronic kidney disease (CKD) patients without history of CV disease. We examined circulating ACE2 activity in CKD patients at stages 3–5 (CKD3-5) and in dialysis (CKD5D) without any history of CV disease. METHODS: Circulating ACE2 activity was measured in human ethylenediamine-tetraacetic acid (EDTA)-plasma samples from the NEFRONA study (n = 2572): control group (CONT) (n = 568), CKD3-5 (n = 1458) and CKD5D (n = 546). Different clinical and analytical variables such as gender; age; history of diabetes mellitus (DM), dyslipidemia and hypertension; glycaemic, renal, lipid and anaemia profiles; vitamin D analogues treatment and antihypertensive treatments (angiotensin-converting enzyme inhibitor and angiotensin receptor blockade) were analysed. Circulating ACE2 and ACE activities were measured using modified fluorimetric assay for EDTA-plasma samples, where zinc chloride was added to recover enzymatic activity. RESULTS: In CKD3-5 and CKD5D, significant decrease in circulating ACE2 activity was observed when compared with CONT, but no differences were found between CKD3-5 and CKD5 when performing paired case-control studies. By multivariate linear regression analysis, male gender and advanced age were identified as independent predictors of ACE2 activity in all groups. Diabetes was identified as independent predictor of ACE2 activity in CKD3-5. Significant increase in the activity of circulating ACE was found in CKD3-5 and CKD5D when compared with CONT and in CKD5D when compared with CKD3-5. By multiple regression analysis, female gender and younger age were identified as independent predictors of ACE activity in CONT and CKD3-5. Diabetes was also identified as an independent predictor of ACE activity in CKD3-5 patients. CONCLUSIONS: Circulating ACE2 and ACE activities can be measured in human EDTA-plasma samples with zinc added to recover enzymatic activity. In a CKD population without previous history of CV disease, ACE2 activity from human EDTA-plasma samples directly correlated with the classical CV risk factors namely older age, diabetes and male gender. Our data suggest that circulating ACE2 is altered in CKD patients at risk for CV event.
has issue date	2015-03-26(xsd:dateTime)
bibo:doi	10.1093/ndt/gfv025
bibo:pmid	25813276
has license	no-cc
sha1sum (hex)	ce9acda036d58398866dfc8c3eadaf70e45ed786
schema:url	https://doi.org/10.1093/ndt/gfv025
resource representing a document's title	Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease
has PubMed Central identifier	PMC7107869
has PubMed identifier	25813276
schema:publication	Nephrol Dial Transplant
resource representing a document's body	covid:ce9acda036d58398866dfc8c3eadaf70e45ed786#body_text
is schema:about of	named entity 'history' named entity 'samples' named entity 'analysed' named entity 'ACE2' named entity 'vitamin D' named entity 'acid' named entity 'ANGIOTENSIN-CONVERTING ENZYME 2' named entity 'CARDIOVASCULAR' named entity 'SAMPLES' named entity 'PATIENTS' named entity 'HAVE' named entity 'MODIFIED' named entity 'ANAEMIA' named entity 'ABOUT' named entity 'CKD' named entity 'ANALYTICAL' named entity 'USING' named entity 'ACE' named entity 'CONTROL GROUP' named entity 'INFORMATION' named entity 'BLOCKADE' named entity 'ANGIOTENSIN-CONVERTING ENZYME 2' named entity 'HUMAN' named entity 'MEASURED' named entity 'DYSLIPIDEMIA' named entity 'CIRCULATING' named entity 'DIALYSIS' named entity 'EXAMINED' named entity 'CLINICAL' named entity 'ASSAY' named entity 'DIFFERENT' named entity 'ACID' named entity 'STUDY' named entity 'BUT' named entity 'METHODS' named entity 'CONVERTING' named entity 'ETHYLENEDIAMINE' named entity 'DIABETES MELLITUS' named entity 'HISTORY OF CARDIOVASCULAR DISEASE' named entity 'ACTIVITY' named entity 'ZINC CHLORIDE' named entity 'LITTLE' named entity 'CIRCULATING' named entity 'CHRONIC KIDNEY DISEASE' named entity 'TREATMENTS' named entity 'TREATMENT' named entity 'ENZYME INHIBITOR' named entity 'HYPERTENSION' named entity 'EDTA' named entity 'CHANGES' named entity 'PREVIOUS' named entity 'BACKGROUND' named entity 'CHRONIC KIDNEY DISEASE' named entity 'PLASMA' named entity 'ANTIHYPERTENSIVE' named entity 'WHERE' named entity 'VITAMIN D' named entity 'INCREASED' named entity 'RECOVER' named entity 'PATIENTS' named entity 'STAGES' named entity 'ACE2' named entity 'ANGIOTENSIN RECEPTOR' named entity 'LIPID' named entity 'ACTIVITIES' named entity 'HISTORY OF' named entity 'CV DISEASE' named entity 'VARIABLES' named entity 'AGE' named entity 'ACTIVITY' named entity 'GENDER' named entity 'ENZYMATIC ACTIVITY' named entity 'ADDED'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software